NCT07371806

Brief Summary

Coronary artery disease (CAD) is a common cardiovascular condition characterized by the narrowing or blockage of the coronary arteries that supply oxygen-rich blood to the heart muscle. CAD represents a significant cause of morbidity and mortality, particularly among individuals aged 40 and older, affecting millions of men and women worldwide. Patients with CAD experience not only physical symptoms but also psychological challenges, including stress and anxiety, which can negatively impact quality of life. In recent years, mindfulness-based interventions have emerged as scientifically supported approaches to help individuals with chronic diseases manage stress and enhance emotional regulation skills. While the existing literature includes studies evaluating the effects of mindfulness-based interventions in CAD and other cardiovascular conditions, most investigations address mixed patient populations and do not thoroughly examine sex-specific differences. Notably, women with CAD may experience symptoms and psychological effects differently than men. Therefore, there is a need for tailored, comprehensive intervention models that address the multidimensional needs of female patients, including stress management, anxiety reduction, and empowerment. This study aims to evaluate the effectiveness of mindfulness-based interventions in women with CAD, providing a targeted approach that addresses both clinical and psychosocial outcomes. The findings are expected to offer valuable insights into improving quality of life and enhancing coping strategies for women living with chronic cardiovascular disease.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress13%
Apr 2026Oct 2026

First Submitted

Initial submission to the registry

January 20, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 28, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

April 15, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2026

Last Updated

January 29, 2026

Status Verified

January 1, 2026

Enrollment Period

2 months

First QC Date

January 20, 2026

Last Update Submit

January 28, 2026

Conditions

Keywords

Coronary artery diseaseMindfulness-based interventionQuality of life

Outcome Measures

Primary Outcomes (1)

  • Cardiac Quality of Life Scale

    The Heart Quality of Life Scale (HeartQoL) is a reliable instrument developed to assess quality of life in individuals with ischemic heart disease (Oldridge, 2014). The scale consists of 14 items, with 10 assessing physical aspects and 4 assessing emotional aspects. Each item is scored from 0 to 3, with higher scores indicating better quality of life. It can be applied to individuals aged 18 and above. Turkish validity and reliability were established by Duğan (2018).

    Baseline and at the end of the 8-week program

Secondary Outcomes (1)

  • State-Trait Anxiety Inventory - Short Form (STAI-SF)

    Baseline and at the end of the 8-week program

Other Outcomes (1)

  • Coronary Artery Disease Empowerment Scale

    Baseline and at the end of the 8-week program

Study Arms (2)

Mindfulness-Based Intervention Group

EXPERIMENTAL

Participants in the intervention group will take part in an 8-week mindfulness-based program designed to cultivate awareness related to anxiety, psychological resilience, and quality of life in women with coronary artery disease.

Behavioral: Mindfulness-Based Intervention Program

Standard Care in Women with Coronary Artery Disease

NO INTERVENTION

Participants in the control group will receive standard care, including routine medical follow-up and discharge education, without any structured intervention.

Interventions

This intervention is an 8-week structured mindfulness-based program designed to cultivate awareness related to anxiety, psychological resilience, and quality of life in women with coronary artery disease. The program includes meditation, breathing, and mindfulness exercises, distinguishing it from the standard care received by the control group.

Mindfulness-Based Intervention Group

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly female patients with coronary artery disease are eligible to participate in the study.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosed with coronary artery disease (CAD) for at least 1 month.
  • Score of 14 or higher on the Short Form of the State-Trait Anxiety Inventory (STAI-SF) at baseline.
  • At least primary school education.
  • Age between 18 and 50 years.
  • Sexually active.
  • Having an active social network.

You may not qualify if:

  • Individuals with hearing or language impairments that would hinder communication.
  • Women who have entered menopause.
  • Women with psychiatric disorders.
  • Discontinuation Criteria:
  • Participants who choose to withdraw from the study.
  • Participants who miss two intervention sessions.
  • Participants with incomplete data on study forms.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kayseri Şehir Hastanesi

Kayseri, Türki̇ye, 38000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Central Study Contacts

Hatice Penekli, Master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study includes one intervention group and one control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
HATİCE PENEKLİ, PhD Candidate, Faculty of Nursing, Institute of Health Sciences, Erciyes University

Study Record Dates

First Submitted

January 20, 2026

First Posted

January 28, 2026

Study Start

April 15, 2026

Primary Completion (Estimated)

June 15, 2026

Study Completion (Estimated)

October 15, 2026

Last Updated

January 29, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Individual participant information will not be shared at this time, as the study has not yet started and confidentiality must be maintained.

Locations